| 1 |
中华医学会呼吸病学分会哮喘学组. 支气管哮喘防治指南(2016年版)[J]. 中华结核和呼吸杂志，2016, 39(9): 675-697.
|
| 2 |
李喆，莫琳芳，任成山. 支气管哮喘药物治疗现状及进展[J/CD]. 中华肺部疾病杂志(电子版), 2014, 7(5): 571-573.
|
| 3 |
郑凤霞. 吸入型糖皮质激素在支气管哮喘中的临床应用及研究近况[J/CD]. 中华肺部疾病杂志(电子版), 2013, 6(4): 385-387.
|
| 4 |
王长征. 改善支气管哮喘控制现状，需要重视患者的长期管理[J/CD]. 中华肺部疾病杂志(电子版), 2013, 6(4): 296-298.
|
| 5 |
Bateman ED, Hurd SS, Barnes PJ, et al. Global strategy for asthma management and preention: GINA executive summary[J]. Eur Respir J, 2008, 31(1): 143-178.
|
| 6 |
Global Initiative for Chronic Obstructive Lung Disease(GOLD). Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease[J]. Accesed June, 2015. Available:
URL
|
| 7 |
郑凤霞，李春花. 噻托溴铵在治疗慢性阻塞性肺疾病中的应用[J/CD]. 中华肺部疾病杂志(电子版), 2016, 9(6): 688-689.
|
| 8 |
董广锋，刘瑞娟，郭兴华. 噻托溴铵抑制慢性阻塞性肺疾病气道重塑及炎症反应机制的研究进展[J]. 山东医药，2014, 54(42): 106-107.
|
| 9 |
Rodrigo GJ, Rodrigo C. The role of anticholinergics in acute asthma treatment: an evidence-based evaluation[J]. Chest, 2002, 121(6): 1977-1987.
|
| 10 |
Johnson EN, Druey KM. Heterotrimeric G protein signaling: role in asthma and allergic inflammation[J]. J Allergy Clin Immunol, 2002, 109(4): 592-602.
|
| 11 |
Barnes PJ. Biochemical basis of asthma therapy[J]. J Biol Chem, 2011, 286(38): 32899-32905.
|
| 12 |
Matera MG, Cazzola M. ultra-long-acting beta2-adrenoceptor agonists：an emerging therapeutic option for asthma and COPD？[J]. Drugs, 2007, 67(4): 503-515.
|
| 13 |
Pieper MP, Chaudhary NI, Park JE. Acetylcholine-induced proliferation of fibroblasts and myof brobl asts in vitro is inhibited by tiotropium bromide[J]. Life Sci, 2007, 80(24-25): 2270-2273.
|
| 14 |
Befekadu E, Onofrei C, Colice GL. Tiotropium in asthma: a systematic review[J]. J Asthma Allergy, 2014, 7: 11-21.
|
| 15 |
Peters SP, Kunselman SJ, Icitovic N, et al. Tiotropium bromide step-up therapy for adults with uncontrolled asthma[J]. N Engl J Med, 2010, 363(18): 1715-1726.
|
| 16 |
Kersjens HA, Engel M, Dahl R, et al. Tiotropium in asthma poorly controlled with standard combination therapy[J]. N Engl J Med, 2012, 367(13): 1198-1207.
|
| 17 |
Rodrigo GJ, Rodrigo C. Triple inhaled drug protocol for the treatment of acute severe asthma[J]. Chest, 2003, 123(6): 1908-1915.
|
| 18 |
Global Initiative for Asthma. Global Strategy for Asthma Management and Prevention[J]. Accesed May 2015. Available:
URL
|
| 19 |
Braman SS. Refractory asthma: lessons learned from the bronchoscope[J]. Chest, 2012, 141(3): 575-576.
|
| 20 |
Price D, Musgrave SD, Shepstone L, et al. Leukotriene antagonists as first-line or add-on asthma-controller therapy[J]. N Engl J Med, 2011, 364(18): 1695-1707.
|
| 21 |
Tian JW, Chen JW, Chen R, et al. Tiotropium versus placedbo for inadequately controlled asthma: a meta-analysis[J]. Respir Care, 2014, 59(5): 654-666.
|
| 22 |
Gamble J, Stevenson M, McClean E, et al. The prevalence of nonadherence in difficult asthma[J]. Am J Respir Crit Care Med, 2009, 180(9): 817-822.
|
| 23 |
Global Initiative for Asthma. Diagnosis of Asthma, COPD and asthma-COPD overlap syndrome(ACOS). A joint project of GINA and GOLD. Accesed June 2015. Available:
URL
|
| 24 |
Terzano C, Petroianni A, Ricci A, et al. Early protective effects of tiotropium bromide in patients with airways hyperresponsiveness[J]. Eur Rev Med Pharmacol Sci, 2004, 8(6): 259-264.
|
| 25 |
Yoshida M, Nakano T, Fukuyama S, et al. Effects of tiotropium on lung function in severe asthmatice with or without emphy-sematous changes[J]. Pulm Pharmacol Ther, 2013, 26(2): 159-166.
|
| 26 |
Alvarado-Gonzalez A, Arce I. Tiotropium bromide in chronic obstructive pulmonary disease and bronchial asthma[J]. J Clin Med Res, 2015, 7(11): 831-839.
|